-+ 0.00%
-+ 0.00%
-+ 0.00%
3 Canadian AI Healthcare Stocks With Revenue Up To $25 Million
Share
Listen to the news

AI has created a scramble for computing power, and specialist GPU cloud providers now rent out that capacity to power complex models. As big technology groups sign multi year contracts, healthcare becomes one of the clearest real world testing grounds for AI, from diagnosis to drug discovery. This article walks through three Canadian AI healthcare stocks from our screener that aim to tap directly into that shift.

The three stocks below are a small sample from this AI healthcare theme, and the full screen surfaced 2 more companies with equally compelling narratives that are not covered in this article. To identify which ideas deserve the most attention, head into the Transformative Artificial intelligence (AI) Healthcare Stocks screener to filter, analyze, and rank the highest conviction plays.

Telescope Innovations (CNSX:TELI)

Telescope Innovations develops chemical process technology and tools for pharma and chemicals, with its DIRECTINJECT-LC hardware plus software platform and AI-ready reactor work aimed at feeding cleaner reaction data into AI models for faster drug research. The group currently reports about CA$7.3 million in chemical revenue and has a market value near CA$28.7 million.

Telescope Innovations appeals to AI healthcare investors because its DIRECTINJECT-LC system targets the unglamorous bottleneck in drug discovery: getting high quality reaction data into algorithms quickly. It is still early stage and unprofitable, so the payoff from that lab automation push hinges on how one unresolved funding pressure plays out.

That funding question is exactly what the Telescope Innovations financial health report is built to unpack so you can see how much runway Telescope Innovations may have before momentum stalls.

TELI Discounted Cash Flow as at Oct 2026
TELI Discounted Cash Flow as at Oct 2026

Profound Medical (TSX:PRN)

Profound Medical develops AI-powered, MRI-guided systems like TULSA-PRO and Sonalleve that use real-time imaging, robotics and closed-loop algorithms to ablate diseased tissue. The business generated about $19 million from medical technology and has a market value near CA$304 million.

Profound Medical fits the screener theme through TULSA-PRO, where AI-driven feedback loops, robot control and MRI thermometry turn imaging data into precise, incision-free prostate treatment. This type of AI-enabled therapy can command premium procedure economics, depending on how one hospital purchasing decision pattern shifts.

That shift in purchasing behavior is exactly where the risk and upside concentrate for Profound Medical, so it is worth lining that up against the analysis report for Profound Medical to see what the market may be missing.

TSX:PRN 1-Year Stock Price Chart
TSX:PRN 1-Year Stock Price Chart

Perimeter Medical Imaging AI (TSXV:PINK)

Perimeter Medical Imaging AI develops optical coherence tomography systems for real-time margin visualization during cancer surgery, including Claire OCT with ImgAssist AI for AI-guided breast conserving procedures. The business generated about $2 million from medical imaging systems in Canada and has a market value near CA$29.9 million.

Perimeter Medical Imaging AI is directly exposed to the AI healthcare theme through Claire OCT with ImgAssist, which brings real-time algorithm support into the operating room for breast cancer margin assessment. The outlook for revenue and earnings remains closely tied to how hospital adoption trends interact with funding conditions.

Those adoption and funding crosscurrents are exactly why it is worth lining up Perimeter Medical Imaging AI against the 2 key rewards and 3 important warning signs (1 is major!) to see what might be quietly building.

TSXV:PINK Earnings & Revenue History as at Oct 2026
TSXV:PINK Earnings & Revenue History as at Oct 2026

Seeking Alternatives Before Momentum Flies

Fresh ideas often move first, and slower money can get caught chasing momentum after prices start moving sharply higher. Scan these themed shortlists while it matters, while they are still under the radar, and consider your options early.

  • Spot cash-generative potential early by reviewing the 4 high quality undervalued stocks that pair solid balance sheets with earnings power before the crowd calls them obvious.
  • Consider AI infrastructure spending while it is still building by scanning the 55 AI infrastructure stocks powering chips, data centers and networking upgrades.
  • Target durable income streams by assessing the 3 dividend fortresses built around higher yield payouts that still aim to keep risk in check.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending